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The vertebrate hypothalamo–pituitary–gonadal axis is the anatomical framework respon-
sible for reproductive competence and species propagation. Essential to the coordinated
actions of this three-tiered biological system is the fact that the regulatory inputs ulti-
mately converge on the gonadotropin-releasing hormone (GnRH) neuronal system, which
in rodents primarily resides in the preoptic/hypothalamic region. In this short review we
will focus on: (1) the general embryonic temporal and spatial development of the rodent
GnRH neuronal system, (2) the origin(s) of GnRH neurons, and (3) which transcription – and
growth factors have been found to be critical for GnRH neuronal ontogenesis and cellular
fate-specification. Moreover, we ask the question whether the molecular and cellular mech-
anisms involved in GnRH neuronal development may also play a role in the development
of other hypophyseal secreting neuroendocrine cells in the hypothalamus.
Keywords: GnRH, hypothalamus, fibroblast growth factor 8, embryonic and fetal development, neuroendocrine
cells
INTRODUCTION
The ability of an organism to reproduce is of critical impor-
tance to the survival of not only the individual, but also of
the species at large. In mammals, reproduction is under the
tight regulation of a three-tiered body axis that consists of the
neurons found in the preoptic area and hypothalamus, pitu-
itary cells, and gonadal tissues, and therefore has been called
the hypothalamo–pituitary–gonadal (HPG) axis. Functionally,
gonadotropin-releasing hormone (GnRH) neurons are viewed as
the most upstream regulatory component of the HPG axis. Most
GnRH neurons are found around the very anterior tip of the
third ventricle called the organum vasculosum lamina terminalis
(OVLT) and their axons project to the external zone of the median
eminence (ME) in order to release the decapeptide, GnRH, into the
portal vein system. This in turn stimulates gonadotropin produc-
tion and release from the gonadotrophs of the anterior pituitary
into systemic circulation, ultimately causing steroidogenesis and
gametogenesis in the gonads.
Key publications in the late 80s described in detail the neu-
roanatomical embryonic development of GnRH neurons in the
rodent (1, 2). Based on the results of these landmark studies, a
compelling argument has been made favoring that GnRH neu-
rons originate (i.e., born) in the nasal compartment, at the level
of the olfactory placode (OP), and migrate along the nasal septum
to the preoptic region and hypothalamus by following the olfac-
tory, vomeronasal, and terminal nerves (1, 3). Currently, the best
estimates based on measurable GnRH peptide and mRNA levels
suggest that this developmental process begins around embryonic
day (E) 9.5, and is completed around E16.5 (1, 3).
Numerous studies have shown that the number of GnRH neu-
rons in the mammalian brain is very limited. Indeed, the adult
mouse and rat brain has a total of about 800–1000 GnRH neurons
(4–7). Interestingly, there are studies reporting that those adult
GnRH neurons are what remain from a larger pool of approx-
imately 1900–2000 embryonic GnRH neurons found around
E12.75 (7). These studies suggest that in addition to GnRH neuron
path-finding, there is also an inherent selection process that takes
place while GnRH neurons are migrating, which pares down the
number of GnRH neurons in the adult rodent brain to 800–1000
total.
In this review, we will primarily focus on the central por-
tion of the HPG axis; specifically, we will discuss in detail the
mechanisms involved in GnRH neuronal ontogenesis and fate-
specification. Moreover, we will discuss how this knowledge may
be useful for understanding the embryonic development of other
neuroendocrine cell types that have been found in the preoptic
region and the hypothalamus.
PRESUMPTIVE ORIGINS GnRH NEURONS
OLFACTORY PLACODE
As previously alluded to, GnRH neurons are first found outside the
central nervous system (CNS), even though the CNS is their final
residence. Using immunocytochemistry and in situ hybridization,
two landmark studies showed that GnRH expressing cells could
be found only in a specific part of the nasal compartment, the OP,
on E11.5 from which they migrate to the forebrain (1, 3).
Interestingly, proliferation studies showed that the vast major-
ity (∼80%) of mouse GnRH neurons undergo their last division
in the medial–ventral OP between E9.5 and E10.5 (2). These data
suggest that the anatomical localization of GnRH progenitor cell
ontogenesis is localized in the embryonic medial–ventral OP. Inter-
estingly, these post-mitotic GnRH progenitor cells do not express
detectable levels of GnRH mRNA or peptide prior to E11.5 (1,
2). In this sense, one can define the period of GnRH neuronal
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fate-specification to occur between E9.5 and E11.5. The absence
of measurable GnRH peptide prior to E11.5 is a major hurdle for
studying the molecular processes that regulate GnRH neuronal
fate-specification because, at present, the only marker for GnRH
neurons is the ability to express the GnRH peptide itself. There-
fore, post-mitotic OP progenitor cells that are destined to become
GnRH neurons cannot be identified during a large portion of
fate-specification, before they express measurable GnRH peptide
levels. Taken together, these studies make a strong case supporting
the central hypothesis that GnRH progenitor cells are born, and
become post-mitotic in the medial–ventral OP.
Further support for this hypothesis comes from the observa-
tion that humans who are deficient in GnRH signaling not only
exhibit hypogonadotropic hypogonadism, which causes infertility,
but are also completely or partially lacking the ability to smell (i.e.,
anosmia or hyposmia) (8–11). One such reproductive disorder in
humans is known as Kallmann syndrome (KS) (12–16). The pres-
ence of olfactory function defects in KS patients is in line with the
observation that the presumably “newly” born GnRH progenitor
cells are first detected in the medial–ventral OP.
The OP is an ectodermal region that gives rise to both non-
sensory respiratory epithelium and sensory olfactory epithelium.
The olfactory epithelium eventually develops into the main olfac-
tory and vomeronasal systems (17, 18). Ablation studies have
provided supporting evidence for the OP being the birthplace
of GnRH neurons, albeit sometimes ambiguously. For example,
amphibians that undergo OP removal ultimately lack the olfac-
tory epithelium, nerve, and bulb, as well as, GnRH neurons of the
forebrain (19, 20). Interestingly, when the OP is removed in rat and
chick embryos it does not result in total loss of forebrain GnRH
neurons. Rather, small populations of GnRH neurons are found in
the septum of rats, suggesting that these did not arise from the OP
(21, 22). However, it has been argued that the method of ablation
may have allowed some of the OP cells to survive, consequently
allowing the emergence of a limited population of GnRH neurons
to migrate to the septum.
Studies in chicks further pinpointed that forebrain GnRH
neurons are eliminated only when the respiratory epithelium is
ablated, and not the olfactory epithelium (23). Conversely, abla-
tion of the olfactory epithelium does not affect the development of
the GnRH neuronal system in chicks (24, 25). Nonetheless, only
a small percentage of GnRH neurons have been found migrat-
ing from the respiratory epithelium of normal chicks, whilst the
majority of GnRH neurons are from the olfactory epithelium (26).
Studies in mice have shown that GnRH neurons are not exclusively
localized in the olfactory epithelium, but can also be found in the
respiratory epithelium (27) as delineated using the transcription
factor marker activator protein 2α (AP2α). Moreover, AP2α is
reported to be co-localized in some of these newly formed GnRH
neurons (27). In the same study, a number of GnRH neurons were
found to be positive for nestin, which is another marker of the
respiratory epithelium. In contrast, some GnRH neurons do not
express olfactory epithelium markers, such as Mash-1, Math4A,
Math4C/neurogenin1, and NeuroD (27). Taken together, these data
demonstrate that both the respiratory and olfactory epithelium
may contribute significantly to the OP’s ability to generate GnRH
neurons. This conclusion, along with the inability to directly follow
GnRH progenitor cells from their birth (due to lack of a marker
for GnRH neurons other than the GnRH peptide itself) has led to
a proposed alternative birth place of GnRH neurons other than
the olfactory epithelium in the OP (see below).
NEURAL CREST
Studies of the GnRH neuronal system in zebrafish have cast
increasing doubt on the accepted paradigm that GnRH neu-
rons originate solely from within the olfactory epithelium in
the medial–ventral OP. For example, analysis of two knockout
zebrafish strains, you-too and detour, showed that not only is
the pituitary lacking or reduced, but there is also a concomi-
tant loss of hypothalamic GnRH neurons (28, 29). Interestingly,
these animals have normal olfactory organ development suggest-
ing that the loss of GnRH neurons cannot be due to the loss of
the OP. This inconsistency in GnRH neuronal origin may be due
to species differences. Indeed, mouse homologs of the aforemen-
tioned zebrafish pituitary knockouts do not show a loss of GnRH
neurons (30–33). Therefore, we can infer that GnRH progenitor
cells are not likely to originate from the developmental tissues that
give rise to the anterior pituitary in mammals.
In several vertebrate species the neural crest has been implicated
as a possible contributor to the formation of the OP (34–36). This
region arises from the edge of the neural plate and shares a bor-
der with the region that eventually becomes the OP. Neural crest
cells have been shown to migrate toward the presumptive OP,
and therefore, are likely to have contributed specific cell popula-
tions to the developing OP (37). Conclusive evidence supporting
this inference comes from zebrafish studies where premigratory
neural crest cells were labeled with lysinated rhodamine dex-
tran in vivo (38, 39). Subsequent double-labeling studies showed
that a subset of the tagged neural crest cells expressed GnRH
mRNA and peptide during the migratory phase of GnRH neuronal
development (29).
These original data have been recently replicated in mice.
Indeed, a small proportion (i.e., ∼30%) of the GnRH neurons
found in the OP had a genetic lineage similar to cells that arise
in the neural crest (35, 40). However, the other 70% of the total
population of GnRH neurons originated from placodal ectoderm
progenitors. In contrast, recent cell fate tracing studies in chicks
determined that all GnRH progenitors originate from ectoder-
mal placodes, suggesting that the developing neural crest does not
contribute to the emergence of GnRH progenitors in this species
(41). In short, GnRH neurons are likely to originate from both the
neural crest and OP. However, the degree to which each of these
two proliferative zones contributes to the GnRH neuronal system
may be species-dependent.
GENES REGULATING NEUROENDOCRINE CELL
DEVELOPMENT
The anatomical development of hypothalamic neuroendocrine
cells has been studied in much detail since the late 70s. For instance,
Altman and Bayer showed that hypothalamic cells are primarily
born during the second half of rat gestation, and originate from
the neuroepithelium of the fetal third ventricle (42). Since then,
many studies have contributed to the elucidation of the underlying
molecular mechanisms of hypothalamic morphogenesis.
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Unlike other hypothalamic neuroendocrine cells, the origins
of GnRH neurons are extra-hypothalamic; however, the devel-
opment of the GnRH neuronal system is arguably one of the
best-studied neuroendocrine cell systems within the hypothala-
mus. Consequently, it is possible that some of the molecular factors
that have been found to regulate GnRH neuronal development in
the nasal and forebrain compartments may also be relevant, and
involved in the embryonic development of non-GnRH hypothal-
amic neuroendocrine cells, such as those that express vasopressin
and oxytocin.
Due to major advances in molecular techniques over the last
couple of decades it has become possible to genetically screen
individuals with GnRH deficiencies. For example, KS patients
have been extensively screened in order to study whether they
harbor specific gene mutation(s) that may have led to their infer-
tility and olfactory deficits. These studies have identified many
factors regulating fate-specification and migration of GnRH neu-
rons [as reviewed in (43–47)]. Some of these factors and their
contributions are described below.
The first mutated gene to be found in KS patients was anosmin-
1 (as described below) (48–50). Following genetic screening, stud-
ies found further evidence supporting the idea that KS may be the
result of a myriad of mutated genes. Indeed, KS patients have been
shown to harbor hemizygous mutations for fibroblast growth fac-
tor receptor-1 (Fgfr1) (13, 51, 52), fibroblast growth factor 8 (Fgf8)
(14, 15, 53), prokineticin 2 (Prok2) (54) and its receptor (Prokr2)
(55), and chromodomain helicase-DNA-binding 7 (Chd7 ) (56–
58). These studies have been instrumental in providing possible
candidate genes that may play a role in GnRH progenitor cell fate-
specification, and possibly provide further insight into the origin
of GnRH neurons.
ANOSMIN-1
Studies in humans revealed that KAL-1 mutations underlie the
X-linked form of KS in humans (13, 48, 49, 59, 60). KAL-1 (also
known as Anosmin-1) encodes an extracellular matrix protein that
is secreted by the cranial neural crest, a developmental region
in mice from which approximately 30% of the GnRH progeni-
tors originate, and provides autocrine regulation of neural crest
formation in chicks (61). Anosmin-1 plays a role in the reg-
ulation of GnRH neuronal migration in rats and humans by
promoting the formation of the lateral olfactory tract and the
collateral branches of the mitral and tufted cells toward the olfac-
tory cortex (13, 62–65). It does this, in part, by promoting FGF
signaling (66).
There is evidence that anosmin-1 expressing cells are read-
ily found within the hypothalamus in rats and zebrafish (67,
68). Interestingly, recent studies have identified the presence of
anosmin-1 protein within bipolar cells in the most rostral hypo-
thalamic neuroepithelium that lines the third ventricle in rat
embryos (67), which has been shown to be the proliferative zone
that gives rise to many, if not all, hypothalamic neurons (42).
Furthermore, it has been reported that these hypothalamic neu-
roepithelia anosmin-1 positive cells are not detected in the same
region in postnatal rats. Currently, the identity and the function of
these anosmin-1 positive cells are unknown. Based on its function
during GnRH neuron migration, it may be speculated that these
anosmin-1 cells facilitate radial or tangential neuroendocrine cell
migration from the proliferative zone of the third ventricle.
FIBROBLAST GROWTH FACTOR RECEPTOR-1 AND FIBROBLAST
GROWTH FACTOR 8
Studies in humans and rodents have cemented the concept that
FGF signaling is critically important for GnRH progenitor cell
birth and proliferation (15, 16, 69, 70). Moreover, loss-of-function
mutations in both Fgfr1 and Fgf8 have been detected in KS patients
(15, 51). Our basic studies using homozygous Fgfr1 and Fgf8 hypo-
morphic newborn mice showed that the GnRH neuronal system
was reduced (i.e., ∼90%) or completely absent, respectively (14,
15). Moreover, the GnRH neuronal population in the heterozy-
gous Fgfr1 and Fgf8 hypomorphs was also significantly reduced
as compared to the wildtype newborns (14, 15). Following stud-
ies furthermore found evidence that the reduced GnRH neuronal
system in these hypomorphic mice causes abnormal reproduc-
tive function (71). Together, these results provided a fundamental
explanation for the reproductive defects found in KS patients who
harbor Fgfr1 and/or Fgf8 mutations.
The elimination of GnRH neurons likely occurred during the
emergence phase of GnRH neuronal development (i.e., ∼E9.5–
E11.5). In contrast to wildtype E11.5 embryos, no GnRH neurons
were detected in the medial–ventral OP of homozygous Fgf8
hypomorphs (14). Currently, it is unknown whether the elimi-
nation of the GnRH progenitor cells is the cause of abrogated
FGF8-dependent proliferation or cell survival. However, circum-
stantial evidence favors the second option given that the presence
of increased apoptosis has been reported for the E10.5 OP (70).
Subsequent studies in non-GnRH neuroendocrine systems
in the mouse hypothalamus showed that FGF signaling is also
involved in the development of hypothalamic neuroendocrine
cells that express kisspeptin, vasopressin, and oxytocin (70–73).
Specifically, the number of kisspeptin neurons in the adult het-
erozygous hypomorphic Fgfr1 and Fgf8 compound mice was
significantly higher than wildtype mice (71). Currently, it is
unknown whether the increase in kisspeptin neurons in these
compound Fgfr1/Fgf8 mice is the result of increased prolifera-
tion or survival of kisspeptin neurons during embryonic devel-
opment. Alternatively, a more parsimonious explanation could
be that the kisspeptin system has been “ramped” up as a com-
pensatory mechanism to counter the reduction in the number
of GnRH neurons in these compound Fgfr1/Fgf8 hypomor-
phic mice.
It should be noted that FGF signaling may play a role in main-
taining neurochemical phenotype/identity. Indeed, Brooks and
colleagues recently reported a major reduction in the number
of oxytocin neurons in the paraventricular nucleus (PVN) and
supraoptic nucleus (SON) of the hypothalamus (72). Upon further
examination, an interesting divergent role of FGF8 signaling dur-
ing oxytocin neuronal development was detected. Indeed, while
the loss of oxytocin neurons in the SON was correlated with a loss
in the oxyphysin–prohormone levels, this was not the case for the
PVN oxytocin neurons (72). These data indicate that FGF8 signal-
ing plays a role in shaping the hypothalamic oxytocin system on
two levels: anatomy (i.e., cell number) and cellular neuropeptide
processing.
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The hypothalamic vasopressinergic system was also highly
compromised in heterozygous and homozygous Fgf8 hypomor-
phic newborn mice (73). Specifically, the number of vasopressin
neurons was found to be reduced in the PVN, SON, and suprachi-
asmatic nucleus (SCN) (73). Interestingly, the percentage of vaso-
pressin neuronal loss was much higher in the SCN than in the
PVN suggesting a ventral–dorsal gradient in FGF8-dependence.
These results are in line with previous studies showing that Fgf8
mRNA expression in the E13.5 mouse embryo is highest in the
ventral zone of the developing hypothalamus, which diminishes
dorsally (Allen Developing Mouse Brain Atlas). Taken together,
these studies support the proposition that the ventral hypothala-
mic neuroendocrine cells (i.e., vasopressin or oxytocin) are more
dependent, and hence, vulnerable to disruptions in FGF8 signaling
during embryonic development.
PROKINETICIN 2/PROKINETICIN RECEPTOR 2
In contrast to the FGF signaling system, Prok2 (74) and its G-
protein coupled receptor (Prokr2) (75–77) were shown to primar-
ily regulate GnRH neuron migration and neuroendocrine function
in Prok2 and Prokr2 null mutant mouse studies (78–80), which
may underlie the abnormal or absent pubertal onset found in
humans (54, 80).
Prokineticin 2 null animals display a greatly reduced number
of GnRH neurons in the medial preoptic area, and 50% of them
show asymmetric olfactory bulb neurogenesis (78, 80). The loss of
medial preoptic GnRH neurons is likely due to the malformation
of the olfactory vomeronasal axonal pathways (79). Humans with
mutations in Prok2 or Prokr2 present with either KS or normosmic
hypogonadotropic hypogonadism (54,55,81). Interestingly,Prok2
and Prokr2 are not localized in GnRH neurons (80). Due to this
fact, it has been suggested that Prok2/Prokr2 impact GnRH migra-
tion by acting on the fibers that guide GnRH neurons into the
forebrain (82).
Both Prok2 and Prokr2 expression has been localized within
several nuclei of the hypothalamus, most notably in the mouse
SCN and PVN (83). Indeed, Prokr2 null mice have disruptions
in circadian activity and thermoregulation, which are two major
functions of the hypothalamus (84). Thus far, it is unknown
whether the loss of Prokr2 expression causes developmental defects
within the embryonic organization of the SCN. However, it is
known that Prokr2 null mice exhibit defective neuronal progenitor
proliferation and migration from the subventricular zone, which
is likely to underlie the decreased volume of the olfactory bulbs
(85). This defect was further compounded by the increased levels
of olfactory bulb apoptosis (85). Taken together, these data favor
the possibility that Prok2 and Prokr2 may also be involved in the
embryonic organization of hypothalamic neuroendocrine cells.
CHROMODOMAIN HELICASE-DNA-BINDING 7
Chromodomain helicase-DNA-binding 7 mutations have been
causally linked to the main cause of CHARGE syndrome, a disor-
der that is characterized by a number of symptoms, including heart
defects, ocular coloboma, genital hypoplasia, and KS (86). Mouse
studies have shown that Chd7 expression is present in the OP
from E10.5 onward, which could explain why CHARGE syndrome
patients manifest anosmia and hypogonadotropin hypogonadism
(56). In line with these clinical observations, Chd7 null mice have
compromised reproductive fitness and significantly less GnRH
neurons (87). The reduction of GnRH neurons may be linked
to the lower levels of cellular proliferation in the E10.5 OP
(87). Currently, there are no studies implicating that Chd7 might
also play a role in the development of non-GnRH hypothalamic
neuroendocrine cells.
PAX
The PAX family of transcription factors contains a unique DNA
binding sequence known as the paired-box, a DNA binding
homeo-domain (88, 89). To date, there have been 9 Pax genes
isolated and all but PAX-1 have been localized in the developing
CNS (89). This family has been described to be involved in early
animal development and tissue specification.
Pax-6 is of special interest because of its importance during the
development of the eye, olfactory system, and forebrain. Mice with
a semi-dominant point mutation in the Pax-6 gene are known as
small-eye (Sey) (90, 91). Sey homozygotes do not develop eyes or
an OP, and do not survive to birth (92, 93). In mice, Pax-6 expres-
sion can be detected in mice on E8.5 in the eye, olfactory system,
pituitary, brain, and spinal cord (94–96). Furthermore, PAX-6 is
localized in the neocortex, lateral ganglionic eminence, thalamus,
and hypothalamus (97).
Sey heterozygotes survive to postpartum, but suffer varying
degrees of eye malformations (92, 98, 99). Since Sey mice do not
form OPs they have been useful models for examining the ori-
gins of GnRH neurons. Indeed, Sey homozygotes completely lack
GnRH neurons in all regions of the brain (100), which provides
further evidence supporting the medial–ventral OP as the birth
place of GnRH progenitor cells. Of course, the absence of OP
development may also have been detrimental to GnRH progenitor
cells that are of neural crest origin (35).
No direct evidence has been reported about the role of PAX-6
during the hypothalamic neuroendocrine development. However,
mapping studies have shown that Pax-6 expression can be found
in the subventricular neuroepithelium cells of the third ventricle in
the E14.5 mouse hypothalamus (97, 101). Furthermore, anatom-
ical studies in Sey mice have reported that the compartmental-
ization of the embryonic hypothalamus is disrupted causing it to
expand beyond its normal boundaries (101). Furthermore, tracing
studies have shown that the mammillothalamic tract is abnormal
in Sey null mouse hypothalamus (102). Therefore, it is possible
that Pax-6 may be important for the emergence of non-GnRH
hypothalamic neuroendocrine cells, although this has not yet been
studied in great detail.
SOX
The Sox gene family belongs to the high mobility group (HMG)
superfamily (103). These proteins bind to the minor groove of
DNA in a highly sequence-specific manner (104–106). There have
been at least 20 Sox genes identified, which are categorized into
eight classes (A–H). Although the Class B Sox genes are known
to be involved in embryonic neuronal development (107) and
differentiation of the neuroepithelium (108), it is the Class C
Sox genes that provide evidence of a role in the regulation of
GnRH expression. There are two SOX-binding sites located on the
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intron A region of GnRH, which possesses a putative transcrip-
tional enhancer. When tested, only SOX-4 and SOX-11 (members
of Class C) dramatically increased luciferase reporter activity
(109). Both SOX-4 and SOX-11 were localized within ∼80% of
GnRH neurons and found in significantly lower abundance in
non-GnRH hypothalamic cells (109). To our knowledge, there are
no data available describing the role of SOX-4 or SOX-11 during
hypothalamic neuroendocrine cell development.
CONCLUSION
In this short, and by no means exhaustive review we argue that
the molecular mechanisms involved during GnRH neuronal fetal
development may also provide some insights into the develop-
ment of non-GnRH hypothalamic neuroendocrine cells. In gen-
eral this approach has been fruitful in elucidating some aspects
of the molecular underpinning of neuroendocrine cells during
their fetal development. As such, a promising and well-described
candidate seems to be FGF8. Indeed, mice that are hypomorphic
for Fgf8 exhibit dramatic GnRH and non-GnRH hypothalamic
neuroendocrine cell defects (see above). However, there are still
many questions that arise from these observations. For instance,
do these factors affect the proliferation, fate-specification, migra-
tion, and/or survival of hypothalamic neuroepithelium that are
destined to become part of the various neuroendocrine sys-
tems in the hypothalamus? Moreover, do other members of
the reviewed signaling systems also play a role in the devel-
opment of the hypothalamus? The direct examination of these
types of questions will be beneficial in order to better under-
stand the fetal organization of the hypothalamic neuroendocrine
systems.
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